BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹203 Cr | ₹209 Cr | ₹166 Cr | ₹153 Cr | ₹159 Cr |
What is the latest Total Current Liabilities ratio of BAL PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹203 Cr |
Mar2023 | ₹209 Cr |
Mar2022 | ₹166 Cr |
Mar2021 | ₹153 Cr |
Mar2020 | ₹159 Cr |
How is Total Current Liabilities of BAL PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹203 Cr | -3.01 | |
Mar2023 | ₹209 Cr | 26.38 | |
Mar2022 | ₹166 Cr | 8.60 | |
Mar2021 | ₹153 Cr | -4.36 | |
Mar2020 | ₹159 Cr | - |
Compare Total Current Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹146.5 Cr | 2.3% | -11.4% | -22.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 2.6% | -5.1% | -6.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -0.5% | -10.1% | 21.8% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 4.7% | 4.8% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 0.6% | 5.2% | 8.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 4.3% | -0.7% | -11.4% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 2.3% |
-11.4% |
-22.6% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses